A Phase 1 Ascending Dose Study to Assess the Safety and Immunogenicity of Adenovirus Anthrax Vector Candidate Vaccines

Clinical trial NCT01979406 · COMPLETED

Trial details

NCT number: NCT01979406
Sponsor: Emergent BioSolutions
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Anthrax Infection

Start date: 2013-11-01
Primary completion: 2014-10-01
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.